Anti-human immunodeficiency virus activity of polyhydroxy fullerenes in vitro

被引:0
|
作者
Schinazi, RF
Chiang, LY
Wilson, LJ
Cagle, DW
Hill, CL
机构
来源
PROCEEDINGS OF THE SYMPOSIUM ON RECENT ADVANCES IN THE CHEMISTRY AND PHYSICS OF FULLERENES AND RELATED MATERIALS, VOL 4 | 1997年 / 97卷 / 14期
关键词
D O I
暂无
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Polyhydroxy fullerenes (henceforth fullerenols) prepared by three different methods were evaluated for antiviral activity in cell culture. While all the fullerenols were active against HIV-1 in acutely infected primary human lymphocytes (EC50 values of 15-42 mu M in PBMC), none were active against chronically infected H9 cells. The cytotoxicity of the fullerenols ranged from low to very low in PBMC and Vero cells (IC50 greater than or equal to 68-100 mu M), but was more varied in CEM cells (IC50 = 3.4 to > 100 mu M). None of the compounds were as active in PBMC or H9 cells as those for the previously reported Wudl fulleroid and 3'-azido-3'-deoxythymidine (AZT). Two fullerenols had low but selective activity against herpes simplex virus type 1 in Vero cells.
引用
收藏
页码:357 / 360
页数:4
相关论文
共 50 条
  • [31] Crystal structure of actinohivin; A novel anti-human immunodeficiency virus protein
    Tsunoda, Masaru
    Suzuki, Kaoru
    Sagara, Tsubasa
    Takahashi, Atsushi
    Inokoshi, Junji
    Omura, Satoshi
    Sekiguchi, Takeshi
    Takenaka, Akio
    Tanaka, Haruo
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C237 - C237
  • [32] DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees
    Boyer, JD
    Ugen, KE
    Chattergoon, M
    Wang, B
    Shah, A
    Agadjanyan, M
    Bagarazzi, ML
    Javadian, A
    Carrano, R
    Coney, L
    Williams, WV
    Weiner, DB
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06): : 1501 - 1509
  • [33] Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
    Wang, Xiaojun
    Abudu, Aierken
    Son, SungMo
    Dang, Ying
    Venta, Patrick J.
    Zheng, Yong-Hui
    JOURNAL OF VIROLOGY, 2011, 85 (07) : 3142 - 3152
  • [34] In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
    Rossi, R.
    Lichtner, M.
    De Rosa, A.
    Sauzullo, I.
    Mengoni, F.
    Massetti, A. P.
    Mastroianni, C. M.
    Vullo, V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02): : 184 - 190
  • [35] New developments in combination chemotherapy of anti-human immunodeficiency virus drugs
    Johnson, V.A.
    Hirsch, M.S.
    Annals of the New York Academy of Sciences, 1990, 616
  • [36] Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS
    Fletcher, CV
    Goodroad, BK
    Cummins, LM
    Henry, K
    Balfour, HH
    Rhame, FS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1571 - 1574
  • [37] NEONATAL PREVALENCE OF ANTI-HUMAN IMMUNODEFICIENCY VIRUS-ANTIBODIES IN CALIFORNIA
    TRACHTENBERG, AI
    CAPELL, FJ
    VUGIA, DJ
    ASCHER, MS
    KIZER, KW
    PEDIATRICS, 1989, 84 (04) : 745 - 746
  • [38] Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine FTC)
    Liotta, Dennis C.
    Painter, George R.
    ACCOUNTS OF CHEMICAL RESEARCH, 2016, 49 (10) : 2091 - 2098
  • [39] Screening of fungi from Chinese medical plants for anti-human immunodeficiency virus type 1 activity
    Xiang, ZC
    Jiang, Y
    Guo, SX
    JOURNAL OF INTEGRATIVE PLANT BIOLOGY, 2006, 48 (04) : 488 - 490
  • [40] Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication
    Berthoux, L
    Péchoux, C
    Darlix, JL
    JOURNAL OF VIROLOGY, 1999, 73 (12) : 10000 - 10009